Researchers at UC San Francisco are getting closer to being able to predict sudden infant death syndrome, or SIDS.
IntegriChain acquires pharma advisory services firm FCS
The acquisition marks IntegriChain’s seventh expansion. Credit: Gorodenkoff/Shutterstock. IntegriChain, a provider of data-driven commercialisation solutions for the pharmaceutical industry, has acquired pharma advisory and managed